Andrew Hoover Karaba MD PhD
Transplant/Immunocompromised States
Assistant Professor
Join to View Full Profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Karaba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andrew Karaba is an infectious disease specialist based in Baltimore, MD, with subspecialties in transplant and oncology infectious diseases. He graduated from Northwestern University The Feinberg School of Medicine in 2015 and completed his residency and fellowship at Johns Hopkins University. Dr. Karaba is currently an Assistant Professor at Johns Hopkins University School of Medicine. His research expertise includes virology, and immunology. He has published research on the immune responses to HSV, CMV, COVID-19 and RSV.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 2017 - 2020- Johns Hopkins UniversityResidency, Internal Medicine, 2015 - 2017
Northwestern University The Feinberg School of MedicineClass of 2015
Certifications & Licensure
MD State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Respiratory Syncytial Virus Vaccination-Reply.Andrew H Karaba, Dorry L Segev, William A Werbel
JAMA. 2025-06-10 - SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19.Leon L Hsieh, Elizabeth A Thompson, Nirvani P Jairam, Katerina Roznik, Alexis Figueroa
Science Translational Medicine. 2025-05-21 - Optimizing IVIg in Xenotransplantation: A Call to Action.Robin K Avery, Olivia S Kates, Kapil K Saharia, Brian K Lindner, John W Baddley
Transplantation. 2025-04-01
Press Mentions
Immunocompromised Have Heterogeneous Antibody Response to RSV VaccinesJanuary 8th, 2025- Study: RSV Vaccine May Be More Effective at Protecting Healthier Older AdultsJanuary 2nd, 2025
- Immunocompromised Adults Present Weaker Response to RSV VaccinesDecember 31st, 2024
- Join now to see all
Grant Support
- Modulation of Herpes Simplex Virus Pathogenesis by Leucine Rich Repeat Kinase 2JOHNS HOPKINS UNIVERSITY2021–2026
- Modulation of Herpes Simplex Virus Pathogenesis by Leucine Rich Repeat Kinase 2JOHNS HOPKINS UNIVERSITY2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
